Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica ›› 2015, Vol. 37 ›› Issue (1): 113-117.doi: 10.3881/j.issn.1000-503X.2015.01.021

• Orginal Article • Previous Articles     Next Articles

Cancer Biomarkers and Personalized Cancer Medicine

Xue-lin DOU, Chun-mei BAI()   

  1. Department of Medical Oncology,PUMC Hospital,CAMS and PUMC,Beijing 100052,China
  • Received:2014-04-28 Online:2015-02-28 Published:2015-02-12
  • Supported by:
    Supported by the National Natural Sciences Foundation of China(81472785,61435001,81101588)


The development of cancer biomarkers has brought the treatment of cancer from the tumor type-based to molecular target-based,and the latter marks the introduction of personalized cancer medicine(PCM). However,each individual tumor has unique molecular information,and the real PCM should be focused on single individuals and their specific molecular identities.

Key words: personalized cancer medicine, cancer biomarker, non-small cell lung cancer, patient-derived xenografts

CLC Number: